In response to the rulings of the Patents Court within the High Court of Justice for England & Wales on 18th February 2021, MGI makes the following statement: We welcome the Court’s decision to give us the permission to appeal the judgment, and we intend to file its appeal with the Court of Appeal. As permitted by the Court, we will continue to supply sequencing reagents to our existing customers in the UK during the appeal period. Although MGI is appealing aspects of the judgement, i...

In response to an article in the Daily Telegraph published on February 6, MGI would like to point out the following: 1. The article makes factually inaccurate claims. MGI does not produce PCR testing equipment. Also, the NHS and MGI do not have a partnership. 2. As the article itself states, “MGI is not accused of collecting or misusing any genetic data”. We have never collected or misused any genetic data in any of the markets in which we operate, and MGI strenuously rejects any suggestions...

The COVID-19 pandemic is still testing the world in 2021. On January 26th, MGI delivered an automated and integrated nucleic acid testing laboratory (also known asMGI Container Lab) to Medical/Doktor.se, a private clinical group in Sweden. Filip Lind, Business Area Manager at Medical/Doktor.se, said, “in addition to providing solutions for COVID testing, the automated & integrated testing laboratory also offers a series of solutions to detect other viruses, making it worthy of long-term ...

HAIKOU, CHINA, January 28, 2021--MGI’s "mobile nucleic acid testing and gene sequencing" platform starts operation in Haikou, Hainan province. The two laboratories, namely the Container Sequencing Lab, can be used either separately or together. It can provide large-scale nucleic acid testing for Haikou, but also help to decode whole genome sequence of the coronavirus, contributing to the local pandemic control during the Chinese spring festival. There is a higher probability of mutations...

In response to the ruling of the Patents Court within the High Court of Justice for England & Wales on 20 January 2021, MGI makes the following statement: We concur with the court's ruling that Illumina’s European Patent (EP) 1 828 412 to methods of sequencing by synthesis using ascorbic acid is invalid for obviousness and that MGI’s CoolMPS sequencing method does NOT infringe this patent, and also the finding that MGI’s CoolMPS sequencing does NOT infringe the EP 2 021 415 to a linker...

MGI’s engineer, LV Shuai, also an expectant father, works so hard and hardly has time to take care of his wife in the third trimester of her pregnancy. After receiving the assignment to support the Shijiazhuang outbreak control LV Shuai leaves for Shijiazhuang as soon as possible. The laboratory is built up in 10 hours and starts operation in 21 hours with a daily testing capacity up to 1 million samples. (10 samples mixed in 1 tube) Moreover, in order to ensure high-throughput and accu...